Bausch Health Companies Inc. Income Statement
BHC / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Bausch Health Companies Inc. reported $10.3B in revenue and $157M in net income for FY2025. Revenue has grown at a 10.8% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.3B | $9.6B | $8.4B | $8.0B | $8.4B | $8.4B | $8.7B | $9.7B | $2.1B | $2.4B | $10.4B | $8.2B | $5.8B | $3.5B | $2.4B |
| Cost of Revenue | - | - | - | - | - | - | - | - | $2.5B | $2.6B | $2.5B | $2.2B | $1.8B | $905.1M | $683.8M |
| SG&A Expense | $3.4B | $3.3B | $2.6B | $2.4B | $2.6B | $2.5B | $2.6B | $2.8B | $2.6B | $2.8B | $2.7B | $2.0B | $1.3B | $756.1M | $572.5M |
| R&D Expense | $629.0M | $616.0M | $465.0M | $452.0M | $465.0M | $413.0M | $361.0M | $421.0M | $361.0M | $421.0M | $334.0M | $246.0M | $156.8M | $79.1M | $65.7M |
| Operating Income | $1.8B | $1.5B | $450.0M | $676.0M | $450.0M | -$2.4B | $102.0M | -$566.0M | $102.0M | -$566.0M | $1.5B | $2.0B | -$409.5M | $79.7M | $300.0M |
| Interest Expense | $1.6B | $1.4B | $1.4B | $1.5B | $1.4B | $1.7B | $1.8B | - | $1.8B | - | - | - | - | - | - |
| Income Tax | $247.0M | $239.0M | -$87.0M | -$375.0M | -$87.0M | -$10.0M | -$4.1B | -$27.0M | -$4.1B | -$27.0M | $133.0M | $174.0M | -$450.8M | -$278.2M | -$177.6M |
| Net Income | $157.0M | -$46.0M | -$948.0M | -$560.0M | -$948.0M | -$4.1B | $2.4B | -$2.4B | $2.4B | -$2.4B | -$288.0M | $880.0M | -$863.6M | -$116.0M | $159.6M |
| EPS (Basic) | -$1.62 | -$0.62 | -$2.64 | -$1.58 | -$5.08 | - | $6.86 | -$6.94 | -$0.85 | $2.63 | -$2.70 | -$0.38 | $0.52 | -$1.06 | $1.11 |
| EPS (Diluted) | -$1.62 | -$0.62 | -$2.64 | -$1.58 | -$5.08 | -$11.81 | $6.83 | -$6.94 | -$0.85 | $2.58 | -$2.70 | -$0.38 | $0.49 | -$1.06 | $1.11 |
| Shares Outstanding | 367.8M | 365.2M | 361.9M | 359.4M | 355.4M | 352.6M | 349.9M | 348.7M | 347.8M | 342.9M | 334.0M | 333.0M | 303.9M | 306.4M | 302.4M |
| Operating Margin | 17.7% | 16.1% | 5.3% | 8.4% | 5.3% | -28.4% | 1.2% | -5.9% | 4.8% | -23.9% | 14.6% | 24.4% | -7.1% | 2.3% | 12.4% |
| Profit Margin | 1.5% | -0.5% | -11.2% | -7.0% | -11.2% | -49.5% | 27.6% | -24.9% | 114.0% | -101.5% | -2.8% | 10.7% | -15.0% | -3.3% | 6.6% |